CD47 and glioblastoma: Based on the previous studies, Zou et al. [50] prepared the biomimetic nanovesicles named NAcp@CD47, capable of traversing the blood-brain barrier and delivering encapsulated anti-CD47 antibodies and STING agonist to glioblastoma (GBM) [51] to stimulate phagocytosis.